Switch to:
PDL BioPharma Inc (NAS:PDLI)
Cash And Cash Equivalents
$214.5 Mil (As of Jun. 2014)

PDL BioPharma Inc's quarterly cash and cash equivalents increased from Dec. 2013 ($94.3 Mil) to Mar. 2014 ($334.0 Mil) but then declined from Mar. 2014 ($334.0 Mil) to Jun. 2014 ($214.5 Mil).

PDL BioPharma Inc's annual cash and cash equivalents declined from Dec. 2011 ($168.5 Mil) to Dec. 2012 ($131.2 Mil) and declined from Dec. 2012 ($131.2 Mil) to Dec. 2013 ($94.3 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

PDL BioPharma Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
BS_CashAndCashEquivalents 91.4183.4179.0340.6129.3303.2211.6168.5131.294.3

PDL BioPharma Inc Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
BS_CashAndCashEquivalents 141.4184.5132.6131.2182.2251.5319.694.3334.0214.5
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide